Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine with imaginal or in-vivo exposure for public speaking anxiety
ACTRN12610000587000Phase 4Not yet recruiting
- Sponsor
- Macquarie University
- Start
- Sep 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of d-cycloserine in Social Anxiety Disorder (SAD), sponsored by Macquarie University. Planned start Sep 2010; status: not yet recruiting.
02
Drugs
d-cycloserine
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on ACTRN12610000587000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000587000.